Wikoryl AF Drops contain Chlorpheniramine Maleate (2 mg/ml) and Phenylephrine (5 mg/ml), formulated for the symptomatic relief of nasal congestion and allergic conditions. Chlorpheniramine Maleate is a first-generation antihistamine that competitively inhibits H1 histamine receptors, thereby reducing allergic symptoms such as sneezing, itching, and rhinorrhea. Phenylephrine is a selective alpha-1 adrenergic receptor agonist that acts as a decongestant by inducing vasoconstriction in the nasal mucosa, leading to decreased swelling and improved nasal airflow. Wikoryl AF Drops are indicated for the management of allergic rhinitis, common cold symptoms, and other upper respiratory tract allergies where nasal congestion and histamine-mediated symptoms are present. The combination provides both antihistaminic and decongestant effects, offering comprehensive symptomatic relief. Dosage should be administered as directed by a healthcare professional, with caution advised in patients with hypertension, cardiovascular disease, hyperthyroidism, or glaucoma due to the vasoconstrictive properties of Phenylephrine. Use in pediatric and pregnant populations should be under strict medical supervision. Adverse effects may include dizziness, dry mouth, nervousness, or increased blood pressure. Patients are advised to report any unusual symptoms promptly. Wikoryl AF Drops should be stored in a cool, dry place away from direct sunlight.